Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease

被引：0
|
作者：
John W. Ostrominski
Tiffany M. Powell-Wiley
机构：
[1] Brigham and Women’s Hospital and Harvard Medical School,Division of Cardiovascular Medicine
[2] Brigham and Women’s Hospital and Harvard Medical School,Division of Endocrinology, Diabetes and Hypertension
[3] National Heart,Social Determinants of Obesity and Cardiovascular Risk Laboratory, Cardiovascular Branch, Division of Intramural Research
[4] Lung and Blood Institute,Intramural Research Program
[5] National Institutes of Health,undefined
[6] National Institute on Minority Health and Health Disparities,undefined
[7] National Institutes of Health,undefined
来源：
Current Atherosclerosis Reports | 2024年 / 26卷
关键词：
Obesity; Cardiometabolic disease; Prevention; Weight management; Social determinants of health; Pharmacotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 23
页数：12
相关论文
共 50 条
  • [1] Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease
    Ostrominski, John W.
    Powell-Wiley, Tiffany M.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (01) : 11 - 23
  • [2] Risk stratification in secondary cardiovascular prevention
    Lazzeroni, Davide
    Coruzzi, Paolo
    [J]. MINERVA CARDIOANGIOLOGICA, 2018, 66 (04): : 471 - 476
  • [3] OVERWEIGHT OR OBESITY FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN THE PRIMARY CARE SETTING AND CARDIOVASCULAR RISK
    Rodriguez, J.
    Villaverde, C.
    Perez, J.
    Panisello, J.
    Bleda, D.
    Trave, P.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [4] Aspirin for primary cardiovascular prevention: is there a need for risk stratification?
    Aimo, Alberto
    De Caterina, Raffaele
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 (34) : 2922 - 2923
  • [5] Cardiovascular Disease in Women Primary and Secondary Cardiovascular Disease Prevention
    Sanghavi, Monika
    Gulati, Martha
    [J]. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2016, 43 (02) : 265 - +
  • [6] Obesity and cardiovascular disease: From pathophysiology to risk stratification
    Marinou, Kyriakoula
    Tousoulis, Dimitris
    Antonopoulos, Alexios S.
    Stefanadi, Elli
    Stefanadis, Christodoulos
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 138 (01) : 3 - 8
  • [7] Secondary prevention of cardiovascular disease: Time to rethink stratification of disease severity?
    Akyea, Ralph K.
    Kai, Joe
    Qureshi, Nadeem
    Hamid, Hasidah Abdul
    Weng, Stephen F.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (16) : 1778 - 1780
  • [8] Effect of carotid atherosclerosis screening on risk stratification during primary cardiovascular disease prevention
    Bard, RL
    Kalsi, H
    Rubenfire, M
    Wakefield, T
    Fex, B
    Rajagopalan, S
    Brook, RD
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (08): : 1030 - 1032
  • [9] Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification
    Aimo, Alberto
    De Caterina, Raffaele
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2020, 23 (02): : 70 - 78
  • [10] Inflammatory markers for risk stratification in primary prevention of cardiovascular disease: Time for a 'multimarker' approach?
    Ikonomidis, I
    Lekakis, J
    Kremastinos, DT
    [J]. THROMBOSIS AND HAEMOSTASIS, 2006, 95 (03) : 397 - 398
12345